Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2016 07:00 ET | Source: Exicure, Inc.

Exicure Announces Dosing of First Patient in Phase 1 Trial for the Treatment of Chronic Plaque Psoriasis

SKOKIE, Ill., April 26, 2016 (GLOBE NEWSWIRE) -- Exicure, a pioneer in developing Spherical Nucleic Acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, today announced the dosing...
February 12, 2016 11:57 ET | Source: Exicure, Inc.

Exicure Co-Founder Awarded Prestigious Dan David Prize

SKOKIE, Ill., Feb. 12, 2016 (GLOBE NEWSWIRE) -- Exicure is pleased to announce that Chad A. Mirkin, Ph.D., co-founder and director of Exicure, has been named the recipient of the 2016 Dan David...
October 15, 2015 06:00 ET | Source: Exicure, Inc.

Exicure Co-Founder Awarded Inaugural Sackler Prize

SKOKIE, Ill., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Exicure is pleased to announce that Chad A. Mirkin, Ph.D., co-founder and director of Exicure, has been named the inaugural recipient of the Raymond and...
April 22, 2015 16:01 ET | Source: Exicure, Inc.

AuraSense Therapeutics Announces Publication of Preclinical Data Demonstrating Immuno-Modulation by its Proprietary Spherical Nucleic Acid Platform

SKOKIE, Ill., April 22, 2015 (GLOBE NEWSWIRE) -- AuraSense Therapeutics, the pioneer in developing Spherical Nucleic Acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, today...
February 04, 2015 10:36 ET | Source: Exicure, Inc.

AuraSense Therapeutics Adds to Series C Financing

SKOKIE, Ill., Feb. 4, 2015 (GLOBE NEWSWIRE) -- AuraSense Therapeutics, the pioneer in developing Spherical Nucleic Acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, today...
October 01, 2014 09:45 ET | Source: Exicure, Inc.

AuraSense Therapeutics Welcomes Key Personnel, Further Expanding Leadership Team

SKOKIE, Ill., Oct. 1, 2014 (GLOBE NEWSWIRE) -- AuraSense Therapeutics, the pioneer in developing Spherical Nucleic Acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, today...